HBW Advisory Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

HBW Advisory Services’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,097	Closed	-$533K	–	464
2025 Q4	$533K	Buy	+5,097	New	+$513K	0.06%	275
2024 Q4	–	Sell	-5,851	Closed	-$509K	–	401
2024 Q3	$509K	Buy	+5,851	New	+$501K	0.07%	199
2023 Q3	–	Sell	-14,224	Closed	-$1.08M	–	334
2023 Q2	$1.08M	Buy	+14,224	New	+$1.09M	0.23%	103

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Cavalier Investments Alpharetta, Georgia $2.41B AUM 38.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HBW Advisory Services's PJP Position: Q1 2026 in Review

HBW Advisory Services sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2026, closing a stake of 5,097 shares — an estimated $533K sold.

HBW Advisory Services first reported a position in PJP in Q2 2023 and held it in 3 quarters. The position peaked at $1.08M in Q2 2023. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

HBW Advisory Services reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2026 after selling out during the quarter.
HBW Advisory Services sold 5,097 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $533K.
HBW Advisory Services first reported a position in Invesco Pharmaceuticals ETF in Q2 2023 and held it in 3 quarters.
HBW Advisory Services's Invesco Pharmaceuticals ETF position peaked at $1.08M in Q2 2023.
119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on HBW Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.